Your browser doesn't support javascript.
loading
Corrigendum to "Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling" [Biochim. Biophys. Acta Mol. Basis Dis. 1870(1) (2024)166913-25, PMID: 37813168].
Bhattacharyya, Sumit; O-Sullivan, Insug; Tu, Jieqi; Chen, Zhengjia; Tobacman, Joanne K.
Affiliation
  • Bhattacharyya S; Jesse Brown VA Medical Center, Chicago, IL 60612, USA; Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
  • O-Sullivan I; Jesse Brown VA Medical Center, Chicago, IL 60612, USA; Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
  • Tu J; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL 60612, USA.
  • Chen Z; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, Chicago, IL 60612, USA; Biostatistics Shared Resource, University of Illinois Cancer Center, Chicago, IL 60612, USA.
  • Tobacman JK; Jesse Brown VA Medical Center, Chicago, IL 60612, USA; Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA. Electronic address: jkt@uic.edu.
Biochim Biophys Acta Mol Basis Dis ; 1870(6): 167231, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38760288
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biochim Biophys Acta Mol Basis Dis Year: 2024 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biochim Biophys Acta Mol Basis Dis Year: 2024 Type: Article Affiliation country: United States